1. Home
  2. BRNS vs BODI Comparison

BRNS vs BODI Comparison

Compare BRNS & BODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRNS
  • BODI
  • Stock Information
  • Founded
  • BRNS 2016
  • BODI 1998
  • Country
  • BRNS United Kingdom
  • BODI United States
  • Employees
  • BRNS N/A
  • BODI N/A
  • Industry
  • BRNS Biotechnology: Pharmaceutical Preparations
  • BODI Industrial Machinery/Components
  • Sector
  • BRNS Health Care
  • BODI Industrials
  • Exchange
  • BRNS Nasdaq
  • BODI Nasdaq
  • Market Cap
  • BRNS 48.3M
  • BODI 40.1M
  • IPO Year
  • BRNS 2021
  • BODI N/A
  • Fundamental
  • Price
  • BRNS $1.07
  • BODI $6.90
  • Analyst Decision
  • BRNS Strong Buy
  • BODI Buy
  • Analyst Count
  • BRNS 1
  • BODI 2
  • Target Price
  • BRNS $3.00
  • BODI $10.00
  • AVG Volume (30 Days)
  • BRNS 42.9K
  • BODI 14.7K
  • Earning Date
  • BRNS 11-05-2025
  • BODI 11-11-2025
  • Dividend Yield
  • BRNS N/A
  • BODI N/A
  • EPS Growth
  • BRNS N/A
  • BODI N/A
  • EPS
  • BRNS N/A
  • BODI N/A
  • Revenue
  • BRNS $14,969,000.00
  • BODI $324,871,000.00
  • Revenue This Year
  • BRNS N/A
  • BODI N/A
  • Revenue Next Year
  • BRNS N/A
  • BODI N/A
  • P/E Ratio
  • BRNS N/A
  • BODI N/A
  • Revenue Growth
  • BRNS 1766.46
  • BODI N/A
  • 52 Week Low
  • BRNS $0.64
  • BODI $3.38
  • 52 Week High
  • BRNS $2.92
  • BODI $8.71
  • Technical
  • Relative Strength Index (RSI)
  • BRNS 41.80
  • BODI 70.15
  • Support Level
  • BRNS $1.08
  • BODI $5.30
  • Resistance Level
  • BRNS $1.20
  • BODI $7.29
  • Average True Range (ATR)
  • BRNS 0.10
  • BODI 0.47
  • MACD
  • BRNS -0.01
  • BODI 0.11
  • Stochastic Oscillator
  • BRNS 22.16
  • BODI 82.03

About BRNS Barinthus Biotherapeutics plc

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.

About BODI The Beachbody Company Inc. Class A Common Stock

The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.

Share on Social Networks: